Search This Blog

Wednesday, April 27, 2022

Integra LifeSciences Reports First Quarter 2022

 First Quarter 2022 Highlights

  • Revenues of $376.6 million increased 4.6% on a reported basis and 5.6% on an organic basis compared to the prior year.

  • GAAP earnings per diluted share of $0.39, compared to $0.53 in the first quarter of 2021; adjusted earnings per diluted share of $0.74, compared to $0.69 in the prior year.

  • The Company is raising its previous full-year 2022 organic growth guidance of 3.5% to 5% to a new range of 3.8% to 5.2%, reflecting the better than expected first quarter revenue results. Reported revenue growth is reaffirmed at 2.5% to 3.5%. Adjusted earnings per share guidance range reaffirmed at $3.27 to $3.35.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.